D
Deepak Suri
Researcher at Whittington Hospital
Publications - 9
Citations - 320
Deepak Suri is an academic researcher from Whittington Hospital. The author has contributed to research in topics: Cirrhosis & Fatty liver. The author has an hindex of 3, co-authored 9 publications receiving 185 citations. Previous affiliations of Deepak Suri include University College London Hospitals NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
Ankur Srivastava,R. Gailer,R. Gailer,Sudeep Tanwar,Sudeep Tanwar,P M Trembling,P M Trembling,Julie Parkes,Alison Rodger,Deepak Suri,Douglas Thorburn,Douglas Thorburn,K. Sennett,S. Morgan,Emmanuel Tsochatzis,Emmanuel Tsochatzis,William Rosenberg,William Rosenberg +17 more
TL;DR: It is shown that established blood tests for liver fibrosis can be used in primary care to stratify patients with fatty liver disease, leading to a reduction in unnecessary referrals by 80% and greatly improving the detection of cases of advanced fibrosis and cirrhosis.
Journal ArticleDOI
Detection of metallic cobalt and chromium liver deposition following failed hip replacement using T2* and R2 magnetic resonance
Amna Abdel-Gadir,Reshid Berber,John B. Porter,Paul D. Quinn,Deepak Suri,Peter Kellman,Alister Hart,James C. Moon,James C. Moon,Charlotte Manisty,Charlotte Manisty,John A. Skinner +11 more
TL;DR: T2* and R2 quantification of liver metal deposition in a patient with a failed hip implant is demonstrated, demonstrating heavy elemental cobalt and chromium deposition in macrophages, and no detectable iron.
Journal ArticleDOI
Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals
Gauri Godbole,Dianne Irish,Marina Basarab,Tabitha Mahungu,Andrew Fox-Lewis,Claire Thorne,Michael Jacobs,Geoffrey Dusheiko,William Rosenberg,Deepak Suri,Andrew Millar,Eleni Nastouli +11 more
TL;DR: In certain sectors of London, implementation of the pathway for management of women with hepatitis B and their infants is suboptimal and improved intersectorial sharing of information is needed to reduce the risk of women of high infectivity being lost to follow up.
The impact of virologic resistance and adherence on treatment failure in a cohort of hepatitis C virus (HCV) infected patients treated with telaprevir (TVR) and boceprevir (BOC)
C Velazquez,Malcolm J Macartney,Dianne Irish,S Tanwar,P M Trembling,BJ Hogan,J Catt,S Glasgow,L Winter,M Ju,M.T. Moore,M Hains,Belinda Claire Smith,Deepak Suri,Michael R. Jacobs,Jude A. Oben,Eleni Nastouli,Clare Booth,Simon H. Bridge,Ana Garcia-Diaz,Adele L. McCormick,Geoff Dusheiko,William Rosenberg,Tanzina Haque +23 more
Journal ArticleDOI
Thrombotic microangiopathy (TMA) in a patient treated with antiviral therapy for hepatitis C
TL;DR: A 53-year-old woman presented to the emergency department having collapsed in the hepatology outpatient unit having collapsed having been started on peginterferon-α, ribavirin and telaprevir for treatment of hepatitis C (genotype 1) 12 weeks prior to admission.